Suppr超能文献

牛奶过敏患者亚组中酪蛋白特异性免疫球蛋白显示,耐受患者中出现向IgA优势的转变。

Casein-specific immunoglobulins in cow's milk allergic patient subgroups reveal a shift to IgA dominance in tolerant patients.

作者信息

Sletten Gaynour B G, Halvorsen Ragnhild, Egaas Eliann, Halstensen Trond S

机构信息

National Veterinary Institute, Oslo, Norway.

出版信息

Pediatr Allergy Immunol. 2007 Feb;18(1):71-80. doi: 10.1111/j.1399-3038.2006.00489.x.

Abstract

Differences in casein-specific immunoglobulin (Ig) G-subclass and IgA serum levels between reactive and tolerant patients may hint at the immunopathogenesis during tolerance development in cow's milk allergy (CMA). alpha-, beta- and kappa-casein-specific IgG(1), IgG(4), IgE and IgA serum levels were compared in clinically reactive and tolerized IgE-mediated (n = 15) and non-IgE-mediated (n = 14) CMA with delayed gastrointestinal symptoms, using enzyme-linked immunosorbent assay (ELISA) and immunoblot techniques. The median anti-casein IgE levels in clinically reactive IgE-mediated CMA patients (n = 9) were 140- to 180-fold higher than in tolerized patients (n = 6) and 160- to 200-fold higher than in controls (n = 10). Median alpha-, beta- and kappa-casein-specific IgG(1) and IgG(4) levels were nine- to 60-fold higher in reactive patients and five- to 60-fold in tolerized patients. Clinical tolerance in IgE-mediated CMA was thus associated with decreased casein-specific IgE, IgG(4) and IgG(1), whereas serum IgA anti-alpha -, beta- and kappa-casein remained practically unaltered. Tolerized cow's milk protein (CMP)-sensitive atopic dermatitis had, in particular, decreased kappa-casein-specific IgG(1) levels, compared with clinically reactive patients. The ELISA levels to immunoblot correlation profile for the alpha-, beta- and kappa-casein-specific IgE suggested that the IgE-mediated CMA patients predominantly reacted to tertiary alpha- and beta-casein epitopes whereas the IgE in non-IgE-mediated patients reacted to linearized alpha-, beta- and kappa-casein epitopes. Clinical tolerance in non-IgE-mediated CMA patients (n = 9) was associated with a four- to 10-fold decrease in casein-specific IgE levels, accompanied by a five- to eightfold decrease in IgG(1) and five- to 60-fold decrease in IgG(4) levels, whereas casein-specific IgA levels remained unaltered. Thus, tolerance in both patient groups was characterized by a generalized decreased humoral immune response to caseins, which induced a functional shift to IgA dominance.

摘要

反应性患者与耐受患者之间酪蛋白特异性免疫球蛋白(Ig)G亚类和IgA血清水平的差异,可能暗示牛奶过敏(CMA)耐受形成过程中的免疫发病机制。采用酶联免疫吸附测定(ELISA)和免疫印迹技术,比较了具有延迟胃肠道症状的临床反应性和耐受的IgE介导(n = 15)和非IgE介导(n = 14)CMA患者中α-、β-和κ-酪蛋白特异性IgG(1)、IgG(4)、IgE和IgA血清水平。临床反应性IgE介导的CMA患者(n = 9)中抗酪蛋白IgE水平中位数比耐受患者(n = 6)高140至180倍,比对照组(n = 10)高160至200倍。反应性患者中α-、β-和κ-酪蛋白特异性IgG(1)和IgG(4)水平中位数比耐受患者高9至60倍。因此,IgE介导的CMA中的临床耐受与酪蛋白特异性IgE、IgG(4)和IgG(1)降低有关,而血清IgA抗α-、β-和κ-酪蛋白水平基本未改变。与临床反应性患者相比,耐受的牛奶蛋白(CMP)敏感的特应性皮炎患者中,κ-酪蛋白特异性IgG(1)水平尤其降低。α-、β-和κ-酪蛋白特异性IgE的ELISA水平与免疫印迹相关性图谱表明,IgE介导的CMA患者主要对三级α-和β-酪蛋白表位起反应,而非IgE介导患者中的IgE对线性化的α-、β-和κ-酪蛋白表位起反应。非IgE介导的CMA患者(n = 9)中的临床耐受与酪蛋白特异性IgE水平降低4至10倍有关,同时IgG(1)降低5至8倍,IgG(4)降低5至60倍,而酪蛋白特异性IgA水平未改变。因此,两组患者的耐受特征均为对酪蛋白的体液免疫反应普遍降低,这导致了向IgA主导的功能转变。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验